Release kinetics of N-terminal pro-B-type natriuretic peptide in a clinical model of acute myocardial infarction

Clin Chim Acta. 2014 Feb 15:429:34-7. doi: 10.1016/j.cca.2013.11.017. Epub 2013 Dec 1.

Abstract

Background: N-terminal segment of B-type natriuretic peptide prohormone (NT-proBNP) is elevated in patients with acute myocardial infarction (AMI) thus providing both diagnostic information and prognostic information. The aim of the present study was to determine the time course of NT-proBNP release in patients undergoing transcoronary ablation of septal hypertrophy (TASH) a procedure mimicking AMI.

Methods: We analyzed the release kinetics of NT-proBNP in 18 consecutive patients with hypertrophic obstructive cardiomyopathy undergoing TASH. Serum samples were collected prior to and at 15, 30, 45, 60, 75, 90, and 105 min, and 2, 4, 8, and 24h after TASH.

Results: NT-proBNP concentrations showed a continuous increase during the first 75 min with a significant percent change compared to baseline value already 15 min after TASH (105.6% [IQR 102.2-112.7]; P<0.001). All patients had a significant increase of NT-proBNP at 45 min (range of percent increase [min-max]: 103.5-137.2%; range of absolute increase [min-max]: 23.5-304.0 ng/L). NT-proBNP concentrations decreased below the baseline value until the 8th h after initiation of myocardial infarction.

Conclusion: NT-proBNP concentration increases immediately after induction of myocardial infarction proving early evidence of myocardial injury despite the decrease of the left ventricular wall stress due to the TASH related reduction of the left ventricular outflow gradient.

Keywords: N-terminal pro-B-type natriuretic peptide; Release kinetics; Transcoronary ablation of septal hypertrophy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ablation Techniques
  • Acute Disease
  • Atrial Natriuretic Factor / metabolism*
  • Female
  • Heart Septum / pathology
  • Humans
  • Hypertrophy / complications
  • Hypertrophy / therapy
  • Kinetics
  • Male
  • Middle Aged
  • Myocardial Infarction / complications*
  • Myocardial Infarction / metabolism*
  • Myocardial Infarction / therapy
  • Protein Precursors / metabolism*

Substances

  • N-terminal proatrial natriuretic peptide
  • Protein Precursors
  • Atrial Natriuretic Factor